Cite Filings / OTLK / 0001104659-19-076834
Feed Companies Filings Check
Sign in
Cite Filings

Pages

  • Feed
  • Companies
  • Filings
  • Check a claim

Account

  • Sign in
  • Create an account
Support (opens in new tab)
SC 13D/A

Beneficial Ownership Report

Outlook Therapeutics, Inc. · Filed 2019-12-30 · Acc 0001104659-19-076834

Documents 1

  • SC 13D/A Beneficial Ownership Report , tm1928317d1_sc13da.htm

Around this filing

  • 2020-01-31 SC 13D/A Beneficial Ownership Report
  • 2019-12-31 4 Options or other derivatives
  • 2019-12-30 4 Director acquired 2,909,091 shares (option exercise)
  • 2019-12-30 SC 13D/A Beneficial Ownership Report
  • 2019-12-23 424B3 Prospectus
  • 2019-12-23 8-K Material agreement · New debt or obligation · Delisting notice · Unregistered share sale · Shareholder rights changed · Other events
  • 2019-06-19 SC 13D/A Beneficial Ownership Report

Link to a passage

At least 12 characters, not counting spaces, so the link points to one passage.

External

  • SEC EDGAR (opens in new tab)
Loading tm1928317d1_sc13da.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…